Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07671937 · ClinicalTrials.gov registry record · NA
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
A NA study, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- NA
- Development phase
- 2,748
- Enrollment target
NCT07671937: Clinical Trial NA study, sponsored by University of Alabama at Birmingham.
NCT07671937 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 2,748 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07671937, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 2,748 participants
- Enrollment target
Study Summary
The purpose of the study is to characterize baseline multidisciplinary tumor board (MDTB) context and variability, evaluate the relationship between baseline fitness of patients with cancer and initial treatment recommendations, and assess the impact of the INSPIRE intervention, which involves including electronic patient reported outcomes (ePROs) within MDTB on MDTB discussion content, provider burden, treatment recommended and received, healthcare utilization, and patient-reported outcomes.
Primary Outcome
Any dose reduction or delay during treatment.
Interventions
- BEHAVIORAL INSPIRE (INtegrating Systematic PatIent-Reported Evaluations)
- BEHAVIORAL Capture of patient-reported outcomes
- BEHAVIORAL Enhanced Clinician Awareness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,748 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2031-07 |
| Phase | NA |
What is known before NCT07671937 opens enrollment
NCT07671937 is an interventional study that assigns participants to a tested intervention. Its 2,748 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% higher).
The record links to 0 conditions, and to 3 interventions - of which INSPIRE (INtegrating Systematic PatIent-Reported Evaluations) is the first listed.
NCT07671937 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07671937 about?
NCT07671937 is a clinical study titled "INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study". The purpose of the study is to characterize baseline multidisciplinary tumor board (MDTB) context and variability, evaluate the relationship between baseline fitness of patients with cancer and initial treatment recommendations, and assess the impact of the INSPIRE intervention, which involves inclu...
What is the current status of trial NCT07671937?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 2,748 participants. The study started on 2026-09-01. Estimated completion is 2031-07.
What interventions are being tested in trial NCT07671937?
The interventions under investigation include: INSPIRE (INtegrating Systematic PatIent-Reported Evaluations) (BEHAVIORAL), Capture of patient-reported outcomes (BEHAVIORAL), Enhanced Clinician Awareness (BEHAVIORAL).
Who is sponsoring clinical trial NCT07671937?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07671937's enrollment target sits among peer trials
2,748 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06085833 · 2,706 participants · NA
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI